# Greenwich LifeSciences, Inc. (GLSI) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Greenwich LifeSciences, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/GLSI/mda/fy2025/): filed 2026-06-01; accession 0001493152-26-026651 (https://www.sec.gov/Archives/edgar/data/1799788/000149315226026651/form10-k.htm); latest 10-K
- [FY 2024 MD&A](/company/GLSI/mda/fy2024/): filed 2025-04-15; accession 0001641172-25-004819 (https://www.sec.gov/Archives/edgar/data/1799788/000164117225004819/form10-k.htm)
- [FY 2023 MD&A](/company/GLSI/mda/fy2023/): filed 2024-04-15; accession 0001493152-24-014625 (https://www.sec.gov/Archives/edgar/data/1799788/000149315224014625/form10-k.htm)
- [FY 2022 MD&A](/company/GLSI/mda/fy2022/): filed 2023-03-31; accession 0001493152-23-010284 (https://www.sec.gov/Archives/edgar/data/1799788/000149315223010284/form10-k.htm)
- [FY 2021 MD&A](/company/GLSI/mda/fy2021/): filed 2022-03-21; accession 0001493152-22-007377 (https://www.sec.gov/Archives/edgar/data/1799788/000149315222007377/form10-k.htm)

Back to /company/GLSI/